English
-
Vectors & Pathogens
-
-
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia
Takeda2 minutes -
Autochthonous dengue in two Dutch visiting Département Var, Southern France (July 2020)
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Dengue: Strategies to Limit Human Exposure to Disease-Carrying Mosquitos
Medscape33 minutes -
The current and future global distribution and population at risk of dengue
Takeda2 minutes -
Antibody-dependent enhancement of severe dengue disease in humans
Takeda2 minutes -
Seasonality and timing of peak abundance of Aedes albopictus in Europe: Implications to public and animal health
Takeda2 minutes -
Dengue fever and insecticide resistance in Aedes mosquitoes in Southeast Asia: a review
Takeda2 minutes -
Pandemic-associated mobility restrictions could cause increases in dengue virus transmission
Takeda2 minutes -
Dengue serotypes
Takeda4 minutes -
Factors associated with the occurrence of dengue epidemics in Brazil: a systematic review
Takeda2 minutes -
Dengue emergence in the temperate Argentinian province of Santa Fe, 2009-2020
Takeda2 minutes -
Mosquito Life Cycle
HHMI BioInteractive3 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021